✦ LIBER ✦

Discovery of [7-(2,6-Dichlorophenyl)-5-methylbenzo[1,2,4]triazin-3-yl]- [4-(2-pyrrolidin-1-ylethoxy)phenyl]amine — A Potent, Orally Active Src Kinase Inhibitor with Antitumor Activity in Preclinical Assays.

✍ Scribed by Glenn Noronha; et al. et al.

Publisher: John Wiley and Sons
Year: 2007
Weight: 13 KB
Volume: 38
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200724209

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Discovery and Precl

ChemInform Abstract: Discovery and Preclinical Studies of 5-Isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo [2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo Active Potent VEGFR-2 Inhibitor.

✍ Rejean Ruel; et al. et al. 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 20 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

ChemInform Abstract: Discovery of (R)-7-

ChemInform Abstract: Discovery of (R)-7-Cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a Farnesyltransferase Inhibitor with Potent Preclinical Antitumor Activity.

✍ John T. Hunt; et al. et al. 📂 Article 📅 2001 🏛 John Wiley and Sons ⚖ 30 KB 👁 1 views